Prescription Required
Inclusive of all taxes
In Treatment of Chronic obstructive pulmonary disease (COPD) COMBITIDE 50MCG/250MCG DISKETTE can help prevent the onset of an asthma attack if it is taken before exercise or exposure to some “triggers”. These may include house dust, pollen, pets, and cigarette smoke. This medicine will allow you to exercise more freely without worrying about getting symptoms such as wheezing, coughing, and shortness of breath. It allows you to live your life more freely without worrying so much about things that set off your symptoms.
It is unsafe to consume alcohol with COMBITIDE 50MCG/250MCG DISKETTE.
COMBITIDE 50MCG/250MCG DISKETTE may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
COMBITIDE 50MCG/250MCG DISKETTE is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether COMBITIDE 50MCG/250MCG DISKETTE alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
COMBITIDE 50MCG/250MCG DISKETTE is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of COMBITIDE 50MCG/250MCG DISKETTE may not be needed in these patients. Please consult your doctor.
COMBITIDE 50MCG/250MCG DISKETTE should be used with caution in patients with liver disease. Dose adjustment of COMBITIDE 50MCG/250MCG DISKETTE may be needed. Please consult your doctor.
If you miss a dose of COMBITIDE 50MCG/250MCG DISKETTE, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenmark Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)